VIP and renal cell carcinoma: Though high-affinity receptors for VIP are also present on CAKI-1 renal cell carcinoma (RCC), it was clearly demonstrated that these receptors do not recognize hGHRH and its analogs and display markedly lower or almost negligible binding to GHRH antagonists such as JV-1-42.